Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

State Council To Inspect Grassroots Health Reform Progress From Mid-September

This article was originally published in PharmAsia News

Executive Summary

China’s State Council will dispatch six teams to inspect health reforms progress and rectify deviations throughout health care institutes in 12 selected provinces.

China’s State Council will dispatch six teams to inspect health reforms progress and rectify deviations throughout health care institutes in 12 selected provinces. The focus will be on essential drug scheme implementation, staffing and staff pay reform arrangements, multi-channel compensation execution, service capacity and employment stability of village doctors. The teams will also inspect the running of other health reform policies including centralized procurement of essential drugs. (Click Here For More - Chinese Language)

"State Council Sends Teams To Inspect Health Reform Progress In Grassroots Health Institutes" - politics.people.com.cn (9/11/2013)

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

SC085450

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel